Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study.
d'Andrea G, Miuli A, Pettorruso M, Cavallotto C, Marrangone C, Cocco A, De Filippis S, Martiadis V, Andriola I, Barlati S, Vita A, Dell'Osso BM, Sensi SL, Di Lorenzo G, Martinotti G. d'Andrea G, et al. Among authors: cavallotto c. J Affect Disord. 2024 Dec 15;367:583-588. doi: 10.1016/j.jad.2024.09.004. Epub 2024 Sep 2. J Affect Disord. 2024. PMID: 39233241
Overcoming treatment-resistant depression with machine-learning based tools: a study protocol combining EEG and clinical data to personalize glutamatergic and brain stimulation interventions (SelecTool Project).
Pettorruso M, Di Lorenzo G, Benatti B, d'Andrea G, Cavallotto C, Carullo R, Mancusi G, Di Marco O, Mammarella G, D'Attilio A, Barlocci E, Rosa I, Cocco A, Padula LP, Bubbico G, Perrucci MG, Guidotti R, D'Andrea A, Marzetti L, Zoratto F, Dell'Osso BM, Martinotti G. Pettorruso M, et al. Among authors: cavallotto c. Front Psychiatry. 2024 Jul 17;15:1436006. doi: 10.3389/fpsyt.2024.1436006. eCollection 2024. Front Psychiatry. 2024. PMID: 39086731 Free PMC article.
Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors.
Mancusi G, Miuli A, Santorelli M, Cavallotto C, Susini O, Pernaci G, Výborová E, Rosa I, d'Onofrio AM, Camardese G, Pettorruso M, Sensi SL, Martinotti G. Mancusi G, et al. Among authors: cavallotto c. Behav Brain Res. 2024 Jul 9;469:115046. doi: 10.1016/j.bbr.2024.115046. Epub 2024 May 16. Behav Brain Res. 2024. PMID: 38761859
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances.
Chiappini S, Vaccaro G, Mosca A, Miuli A, Stigliano G, Stefanelli G, Giovannetti G, Carullo R, d'Andrea G, Di Carlo F, Cavallotto C, Pettorruso M, Di Petta G, Corkery JM, Guirguis A, Stair JL, Martinotti G, Fazel S, Schifano F. Chiappini S, et al. Among authors: cavallotto c. Neurosci Biobehav Rev. 2024 Jul;162:105691. doi: 10.1016/j.neubiorev.2024.105691. Epub 2024 May 10. Neurosci Biobehav Rev. 2024. PMID: 38733894 Free article. Review.
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study.
Chiappini S, Cavallotto C, Mosca A, Di Carlo F, Piro T, Giovannetti G, Pasino A, Vicinelli M, Lorenzini C, Di Paolo M, Pepe M, Di Nicola M, Ricci V, Pettorruso M, Martinotti G. Chiappini S, et al. Among authors: cavallotto c. Pharmaceuticals (Basel). 2024 Apr 21;17(4):535. doi: 10.3390/ph17040535. Pharmaceuticals (Basel). 2024. PMID: 38675495 Free PMC article.
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation.
Cavallotto C, Chiappini S, Mosca A, d'Andrea G, Di Carlo F, Piro T, Susini O, Stefanelli G, Di Cesare A, Ricci V, Pepe M, Dattoli L, Di Nicola M, Pettorruso M, Martinotti G. Cavallotto C, et al. J Clin Med. 2024 Apr 11;13(8):2206. doi: 10.3390/jcm13082206. J Clin Med. 2024. PMID: 38673478 Free PMC article.
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial.
Ostuzzi G, Gastaldon C, Tettamanti M, Cartabia M, Monti I, Aguglia A, Aguglia E, Bartoli F, Callegari C, Canozzi A, Carbone EA, Carrà G, Caruso R, Cavallotti S, Chiappini S, Colasante F, Compri B, D'Agostino A, De Fazio P, de Filippis R, Gari M, Ielmini M, Ingrosso G, Mammarella S, Martinotti G, Rodolico A, Roncone R, Sterzi E, Tarsitani L, Tiberto E, Todini L, Amaddeo F, D'Avanzo B; VESPA Study Group; Barbato A, Barbui C. Ostuzzi G, et al. EClinicalMedicine. 2024 Feb 15;69:102491. doi: 10.1016/j.eclinm.2024.102491. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38384338 Free PMC article.
Corrigendum to "Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine" [Brain Stimul 16 (2023)].
Pettorruso M, d'Andrea G, Di Carlo F, De Risio L, Zoratto F, Miuli A, Benatti B, Vismara M, Pompili E, Nicolò G, Niolu C, Siracusano A, Sensi SL, Dell'Osso B, Di Lorenzo G, Martinotti G; ReModula Study Group. Pettorruso M, et al. Brain Stimul. 2023 Sep-Oct;16(5):1361. doi: 10.1016/j.brs.2023.09.003. Epub 2023 Sep 14. Brain Stimul. 2023. PMID: 37716051 Free article. No abstract available.
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine.
Pettorruso M, d'Andrea G, Di Carlo F, De Risio L, Zoratto F, Miuli A, Benatti B, Vismara M, Pompili E, Nicolò G, Niolu C, Siracusano A, Sensi SS, Dell'Osso B, Di Lorenzo G, Martinotti G; ReModula Study Group. Pettorruso M, et al. Brain Stimul. 2023 Jul-Aug;16(4):1041-1043. doi: 10.1016/j.brs.2023.06.003. Epub 2023 Jun 17. Brain Stimul. 2023. PMID: 37331507 Free article. No abstract available.
14 results